Nitric-oxide production by murine mammary adenocarcinoma cells promotes tumor-cell invasiveness

International Journal of Cancer

Volumn 81, Issue 6, 1999, Pages 889-896

  Orucevic, Amila ^a,b   Bechberger, John ^b   Green, Angela M ^a   Shapiro, Richard A ^a   Billiar, Timothy R ^a   Lala, Peeyush K ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; LIPOPOLYSACCHARIDE; MATRIX METALLOPROTEINASE; MESSENGER RNA; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RECOMBINANT GAMMA INTERFERON; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; CANCER GRAFT; CANCER INVASION; CARCINOMA CELL; CELL INVASION; CONTROLLED STUDY; FEMALE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL LINE; TUMOR GROWTH;

ADENOCARCINOMA; ANIMALS; ENZYME INDUCTION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; INTERFERON-GAMMA, RECOMBINANT; LIPOPOLYSACCHARIDES; LUNG NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C3H; NEOPLASM INVASIVENESS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; OMEGA-N-METHYLARGININE; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TUMOR CELLS, CULTURED;

EID: 0033041452     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990611)81:6<889::AID-IJC9>3.0.CO;2-2     Document Type: Article

References (47)

1. AMBS, S., HUSSAIN, S.P. and HARRIS, C.C., Interactive effects of nitric oxide and p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J., 11, 443-448 (1997).
2. AMBS, S., MERRIAM, W.G., BENNETT, W.P., FELLEY-BOSCO, E., OGUNFUSIKA, M.O., OSER, S.M., KLEIN, S., SHIELDS, P.G., BILLIAR, T.R. and HARRIS, C.C., Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res., 58, 334-341 (1998).
3. ANDRADE, S.P., HART, I.R. and PIPER, P.J., Inhibitors of nitric-oxide synthase selectively reduce flow in tumour-associated neovasculature. Brit. J. Pharmacol., 107, 1092-1095 (1992).
4. BERTAUX, B., HORNEBECK, W., EISEN, A.Z. and DUBERTRET, L., Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. J. invest. Dermatol., 97, 679-685 (1991).
5. BIAN, J., WANG, Y., SMITH, M.R., KIM, H., JACOBS, C., JACKMAN, J., KUNG, H-F., COLBURN, N.H. and SUN, Y., Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP)-3. Carcinogenesis, 17, 1805-1811 (1996).
6. BILLIAR, T.R., Nitric oxide: Novel biology with clinical relevance. Ann. Surg., 221, 339-349 (1995).
7. BRODT, P., PARHAR, R.S., SANKER, P. and LALA, P.K., Studies on clonal heterogeneity in two spontaneously metastasizing mammary carcinomas of recent origin. Int. J. Cancer, 35, 265-273 (1985).
8. BUTTERY, L.D.K., SPRINGALL, D.R., ANDRADE, S.P., RIVEROS-MORENO, V., HART, I., PIPER, P.J. and POLAK, J.M., Induction of nitric oxide synthase in the neovasculature of experimental tumours in mice. J. Pathol., 171, 311-319 (1993).
9. CHHATWAL, V.J.S., NGOI, S.S., CHAN, S.T.F., CHIA, Y.W. and MOOCHHALA, S.M., Aberrant expression of nitric oxide synthase in human polyps, neoplastic colonic mucosa and surrounding peritumoral normal mucosa. Carcinogenesis, 15, 2081-2085 (1994).
10. CHOMCZYNSKI, P. and SACCHI, N., Single-step method of RNA isolation by acid-guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159 (1987).
11. COBBS, C.S., BRENMAN, J.E., ALDAPE, K.D., BREDT, D.S. and ISRAEL, M.A., Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res., 55, 727-730 (1995).
12. EDWARDS, P., CENDAN, J.C., TOPPING, D.B., MOLDAWER, L.L., MACKAY, S., COPELAND, E.M. and LIND, D.S., Tumor cell nitric oxide inhibits cell growth in vitro, but stimulates tumorigenesis and experimental lung metastasis in vivo. J. Surg. Res., 63, 49-52 (1996).
13. FREARS, E.R., ZHANG, Z., BLAKE, D.R., O'CONNELL, J.P. and WINYARD, P.G., Inactivation of tissue inhibitor of metalloproteinase-1 by peroxynitrite. FEBS Lett., 381, 21-24 (1996).
14. FUJIMOTO, H., ANDO, Y., YAMASHITA, T., TERAZAKI, H., TANAKA, Y., SASAKI, J., MATSUMOTO, M., SUGA, M. and ANDO, M., Nitric oxide synthase activity in human lung cancer. Jap. J. Cancer Res., 88, 1190-1198 (1997).
15. FUKUMARA, D. and JAIN, R.K., Role of nitric oxide in angiogenesis and microcirculation in tumors. Cancer Metast. Rev., 17, 77-89 (1998).
16. GALLO, O., MASINI, E., MORBIDELLI, L., FRANCHI, A., FINI-STORCHI, I., VERGARI, W.A. and ZICHE, M., Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J. nat. Cancer Inst., 90, 586-596 (1998).
17. GELLER, D.A., DEVERA, M.E., RUSSELL, D.A., SHAPIRO, R.A., NUSSLER, A.K., SIMMONS, R.L. and BILLIAR, T.R., A central role for IL-1b in the in vitro and in vivo regulation of hepatic inducible nitric oxide synthase. J. Immunol., 155, 4890-4898 (1995).
18. GRAHAM, C.H., HAWLEY, T.S., HAWLEY, R.G., MACDOUGALL, J.R., KERBEL, R.S., KHOO, N. and LALA, P.K., Establishment and characterization of first trimester human trophoblast cells with expanded lifespan. Exp. Cell Res., 206, 204-211 (1993).
19. 15N]nitrate in biological fluids. Anal. Biochem., 126, 131-138 (1982).
20. HAYAKAWA, T., YAMASHITA, K., TANZAWA, K., UCHIJIMA, E. and IWATA, K., Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells: a possible new growth factor in serum. FEBS Lett., 298, 29-32 (1992).
21. JADESKI, L. and LALA, P.K., Role of nitric oxide in mammary tumor angiogenesis. Proc. Amer. Ass. Cancer Res., 39, 378 (1998). (Abstract).
22. JENKINS, D.C., CHARLES, I.G., BAYLIS, S.A., LELCHUK, R., RADOMSKI, M.W. and MONCADA, S., Human colon cancer cell lines show a diverse pattern of nitric-oxide synthase gene expression and nitric oxide generation. Brit. J. Cancer, 70, 847-849 (1994).
23. JENKINS, D.C., CHARLES, I.G., THOMSEN, L.L., MOSS, D.W., HOLMES, L.S., BAYLIS, S.A., RHODES, P., WESTMORE, K., EMSON, P.C. and MONCADA, S., Roles of nitric oxide in tumor growth. Proc. nat. Acad. Sci. (Wash.), 82, 4392-4396 (1995).
24. JUANG, S., XIE, K., XU, L., SHI, Q., WANG, Y., YONEDA, J. and FIDLER, I., Suppression of tumorigenicity and metastasis of human renal carcinoma cells by infection with retroviral vectors harboring the murine inducible nitric-oxide synthase gene. Hum. Gene Ther., 9, 845-854 (1998).
25. KENNOVIN, G.D., HIRST, D.G., STRATFORD, M.R.L. and FLITNEY, F.W., Inducible nitric oxide synthase is expressed in tumour-associated vasculature: inhibition retards tumor growth in vivo. In: S. Moncada, M. Feelisch, R. Busse and E.A. Higgs (eds.), Biology of nitric oxide, Part 4: Enzymology, biochemistry and immunology, pp. 473-479, Portland Press, London (1994).
26. KLOTZ, T., BLOCK, W., VOLBERG, C., ENGELMANN, U. and ADDICKS, K., Selective expression of inducible nitric oxide synthase in human prostate carcinoma. Cancer, 82, 1897-1903 (1998).
27. KNOWLES, R.G. and MONCADA, S., Nitric oxide synthases in mammals. Biochem. J., 298, 249-258 (1994).
28. KONTUREK, S.J., BRZOZOWSKI, T., MAJKA, J., PYTKO-POLONCZYK, J. and STACHURA, J., Inhibition of nitric oxide synthase delays healing of chronic gastric ulcers. Europ. J. Pharmacol., 239, 215-217 (1993).
29. LALA, P.K. and ORUCEVIC, A., Role of nitric oxide in tumor progression: lessons from experimental tumors. Cancer Metast. Rev., 17, 91-106 (1998).
30. LALA, P.K. and PARHAR, R.S., Eradication of spontaneous and experimental adenocarcinoma metastases with chronic indomethacin and intermittent IL-2 therapy. Int. J. Cancer, 54, 677-684 (1993).
31. MOOCHHALA, S., CHHATWAL, V.J.S., CHAN, S.T.F., NGOI, S.S., CHIA, Y.W. and RAUFF, A., Nitric oxide synthase activity and expression in human colorectal cancer. Carcinogenesis, 17, 1171-1174 (1996).
32. MURPHY, A.N., UNSWORTH, E.J. and STETLER-STEVENSON, W.G., Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J. cell. Physiol., 157, 351-358 (1993).
33. MURRELL, G.A.C., JANG, D. and WILLIAMS, R.J., Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem. biophys. Res. Comm., 206, 15-21 (1995).
34. NEMETH, J.A. and GOOLSBY, C.L., TIMP-2, a growth-stimulatory protein from SV-40-transformed human fibroblasts. Exp. Cell Res., 207, 376-382 (1993).
35. G-methyl-L-arginine, an inhibitor of nitric oxide synthesis, on IL-2 induced capillary leakage and anti-tumor responses in healthy and tumor bearing mice. Cancer Immunol. Immunother., 42, 38-46 (1996a).
36. G-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin-2-induced capillary leakage and reduces tumor growth in adenocarcinoma-bearing mice. Brit. J. Cancer, 72, 189-197 (1996b).
37. PALMER, R.M.J., FERRIGE, A.S. and MONCADA, S., Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (Lond.), 327, 524-526 (1987).
38. SUN, Y., KIM, H., PARKER, M., STETLER-STEVENSON, W.G. and COLBURN, N.H., Lack of suppression of tumor cell phenotype by overexpression of TIMP-3 in mouse JB6 tumor cells: identification of a transfectant with increased tumorigenicity and invasiveness. Anticancer Res., 16, 1-8 (1996).
39. TAMURA, T., TAKANISHI, T., KIMURA, Y., SASAKI, K., NORIMATSU, H., TAKAHASHI, K. and TAKIGAWA, M., Nitric oxide mediates interleukin-2-induced matrix degradation and basic fibroblast growth factor release in cultured rabbit articular chondrocytes. A possible mechanism of pathological neovascularization in arthritis. Endocrinology, 137, 3729-3737 (1996).
40. THOMSEN, L.L., LAWTON, F.G., KNOWLES, R.G., BEESLEY, J.E., RIVEROS-MORENO, V. and MONCADA, S., Nitric oxide synthase activity in human gynecological cancer. Cancer Res., 54, 1352-1354 (1994).
41. THOMSEN, L.L. and MILES, D.W., Role of nitric oxide in tumor progression: lessons from human tumors. Cancer Metast. Rev., 17, 107-118 (1998).
42. THOMSEN, L.L., MILES, D.W., HAPPERFIELD, L., BOBROW, L.G., KNOWLES, R.G. and MONCADA, S., Nitric oxide synthase activity in human breast cancer. Brit. J. Cancer, 72, 41-44 (1995).
43. XIE, K. and FIDLER, I.J., Decreased matrix-metalloprotease-2(MMP-2) expression correlates with the suppression of tumorigenicity and metastasis of K-1735 murine melanoma cells transfected with the inducible nitric oxide synthase (iNOS). Amer. Ass. Cancer Res., 38, 524 (1997). (Abstract).
44. XIE, K., HUANG, S., DONO, Z., JUANG, S-H., GUTMAN, M., XIE, Q-W., NATHAN, C. and FIDLER, I.J., Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogated metastasis by K-1735 murine melanoma cells. J. exp. Med, 181, 1333-1343 (1995).
45. ZICHE, M., MORBIDELLI, L., CHOUDHURI, R., ZHANG, H-T., DONNINI, S. and GRANGER, H.J., Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J. clin. Invest., 99, 2625-2634 (1997a).
46. ZICHE, M., MORBIDELLI, L., MASINI, E., AMERINI, S., GRANGER, H.J., MAGGI, C.A., GEPPETTI, P. and LEDDA, F., Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J. clin. Invest., 94, 2036-2044 (1994).
47. ZICHE, M., PARENTI, A., LEDDA, F., DELL'ERA, P., GRANGER, H.J., MAGGI, C.A. and PRESTA, M., Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF. Circ. Res., 80, 845-852 (1997b).